Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6® cells

Human Gene Therapy

Volumn 16, Issue 3, 2005, Pages 393-398

  Gijsbers, Linda ^a   Koel, Björn ^a   Weggeman, Miranda ^a   Goudsmit, Jaap ^a   Havenga, Menzo ^a   Marzio, Giuseppe ^a  

^a CRUCELL HOLLAND BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DNA;

ACCURACY; ARTICLE; ASSAY; CELL IMMORTALIZATION; CONTAMINATION; CONTROLLED STUDY; DNA EXTRACTION; HOST CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SAMPLING; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELL LINE; DNA; DNA PRIMERS; GENE THERAPY; GENETIC VECTORS; HUMANS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 16344371576     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.393     Document Type: Article

References (15)

1. FOOD AND DRUG ADMINISTRATION, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER). (1995). ICH Q2A, Text on validation of analytical procedures.
2. FOOD AND DRUG ADMINISTRATION, CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER). (1996). ICH Q2B, Validation of analytical procedures: Methodology.
3. GONZALEZ, I.L., and SCHMICKEL, R.D. (1986). The human 18S ribosomal RNA gene: evolution and stability. Am. J. Hum. Genet. 38, 419-427.
4. HAQUE, K.A., PFEIFFER, R.M., BEERMAN, M.B., STRUEWING, J.P., CHANOCK, S.J., and BERGEN, A.W. (2003). Performance of high-throughput DNA quantification methods. BMC Biotechnol. 3, 20.
5. KLEIN, D., BUGL, B., GUNZBURG, W.H., and SALMONS, B. (2000). Accurate estimation of transduction efficiency necessitates a multiplex real-time PCR. Gene Ther. 7, 458-463.
6. KLEIN, D. (2002). Quantification using real time PCR technology: applications and limitations. Trends Mol. Med. 8, 257-260.
7. KURTH, R. (1998). Risk potential of the chromosomal insertion of foreign DNA. Dev. Biol. Stand. 93, 45-56.
8. LUBINIECKI, A.S., and PETRICCIANI, J.C. (2001). Recent trends in cell substrate considerations for continuous cell lines. Curr. Opin. Biotechnol. 12, 317-319.
9. PETRICCIANI, J.C., and REGAN, P.J. (1987). Risk of neoplastic transformation from cellular DNA: Calculations using the oncogene model. Dev. Biol. Stand. 68, 43-49.
10. PETRICCIANI, J.C., ADA, G.L., and ROBBINS, F.C. (1987). WHO Study Group on Biologicals: History, issues and goals of the meeting. Dev. Biol. Stand. 68, 1-4.
11. TORCZYNSKI, R.M., FUKE, M., and BOLLON, A.P. (1985). Cloning and sequencing of a human 18S ribosomal RNA gene. DNA 4, 283-291.
12. WALKER, N.J. (2002). A technique whose time has come. Science 296, 557-559.
13. WIERENGA, D.E., COGAN, J., and PETRICCIANI, J.C. (1995). Administration of tumor cell chromatin to immunosuppressed and non-immunosuppressed non-human primates. Biologicals 23, 221-224.
14. WORLD HEALTH ORGANIZATION. (1987). Acceptability of cell substrates for production of biologicals. World Health Organ. Tech. Rep. Ser. 747, 1-29.
15. WORLD HEALTH ORGANIZATION. (1998). WHO Expert Committee on Biological Standardization. World Health Organ. Tech. Rep. Ser. 878, i-vi, 1-101.